The short version
- Why people research itHair growth and scalp/skin support (copper peptide).
- What the evidence isNo trials of injected AHK-Cu.
- What to watchSpreading rash or hives on the scalp.
How AHK-Cu works
Copper-binding peptide focused on hair — promotes follicle growth and dermal microvascularization; the hair-oriented cousin of GHK-Cu.
AHK-Cu is the tripeptide Ala-His-Lys carrying a single copper(II) ion, and the histidine in the middle is the reason the complex exists at all. The imidazole side chain of that histidine residue, the free N-terminal amine, and the deprotonated backbone amide nitrogen between the first two residues together form a chelating pocket that holds Cu(II) in a stable square-planar geometry.
The copper coordination has been modeled rather than assumed. Computational work on the closely related GHK peptide examined how copper binds it and which donor atoms are involved Alshammari 2020. The reason that matters here is practical: the affinity and geometry of the complex determine whether the copper stays on the peptide when it meets a competing ligand, and blood is full of competing ligands.
- Injectable
- Topical
On the goal map: Hair — follicle biology & the androgen problem (Skin, hair & aesthetics)
Research on AHK-Cu4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
No trials of injected AHK-Cu. Topical copper-peptide research is the relevant human evidence, and small controlled work on AHK-Cu specifically reported increased hair follicle size and stimulated dermal papilla cell proliferation.
No completed human trial
Correlative data
Used topically and by injection for hair growth, usually alongside GHK-Cu. Reported experience is of a slower, subtler effect than minoxidil, and the same local reaction at injection sites that every copper peptide produces.
How the mechanism reads
A copper-binding tripeptide (Ala-His-Lys) closely related to GHK-Cu, with activity weighted toward hair follicle rather than general dermal repair — it upregulates VEGF in dermal papilla cells.
MechanisticCopper delivery is the mechanism and the ceiling, exactly as with GHK-Cu: copper is tightly regulated systemically, so more is not straightforwardly better and topical use has a far better rationale than injection.
Mechanistic
Sources
- Pyo HK, Yoo HG, Won CH, Lee SH, Kang YJ, Eun HC, Cho KH, Kim KH. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res 2007 · PMID 17703734
- Fan C, Zhang Y, Wang J. Overview of Short Peptides for Hair Loss. Biomedicines 2026 · PMID 42072405
- Simeon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci 2000 · PMID 11045606
- Alshammari N, Platts JA. Theoretical study of copper binding to GHK peptide. Comput Biol Chem 2020 · PMID 32371360
- Gruchlik A, Jurzak M, Chodurek E, Dzierzewicz Z. Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 secretion in normal human dermal fibroblasts. Acta Pol Pharm 2012 · PMID 23285694
AHK-Cu safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Wilson's disease or any copper-handling disorder.
- Copper or metal-contact allergy.
- Unexplained scalp lesions, which need a diagnosis before anything is applied.
- Pregnancy or breastfeeding, when copper balance is tightly regulated by the placenta.
What’s expected
- Mild scalp tingling or pinkness on topical use.
- A shedding phase as follicles cycle before regrowth reads as thicker hair.
- Slight skin dryness from the carrier rather than the peptide.
Watch for
- Spreading rash or hives on the scalp.
- Metallic taste, nausea or belly pain, the copper-excess pattern.
- Yellowing of the eyes.
Labs that tell you it’s working
- Copper, Serum: a rising value shows copper is entering the blood.
- Ceruloplasmin: the copper-carrying protein, which moves with total copper status.
- Zinc, Plasma: copper loading competes with zinc, so a falling zinc is the early tell.
- Complete Blood Count: low copper or low zinc balance shows as anemia or low white cells.
Copper(II)-binding tripeptide (Ala-His-Lys) delivering copper to follicles; risk is the metal, not the peptide. PMID 17703734 PMID 23285694
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
AHK-Cu FAQ4 common questions
- Is AHK-Cu approved for human use?
- No. AHK-Cu is a research compound. No completed randomized human trial has given it yet.
- What is AHK-Cu researched for?
- Hair growth and scalp/skin support (copper peptide).
- Which labs show whether it's doing anything?
- Copper, Serum; Ceruloplasmin; Zinc, Plasma; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for AHK-Cu: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




